Form 4: Gilead Sciences Executive Deborah H. Telman Reports Stock Transactions

EVP Deborah H. Telman reports stock transactions involving Gilead Sciences common stock, including the vesting and disposal of restricted stock units.

Summary

• On September 10, 2024, Deborah H. Telman, EVP, Corporate Affairs & GC of Gilead Sciences, Inc., reported transactions involving the company's common stock.
• Telman disposed of 307 shares of common stock at a price of $81.44 per share.
• She also acquired 639 shares through the vesting of restricted stock units.
• Following these transactions, Telman directly owns 20,707 shares of Gilead Sciences common stock.
• The reported transactions involved the vesting of restricted stock units granted to Telman, which vest over a four-year schedule.

Sentiment

Score: 5

Explanation: Neutral sentiment as the document simply reports stock transactions by an executive, which is a routine occurrence.

Positives

• The vesting of restricted stock units indicates a continued alignment of the executive's interests with those of the company and its shareholders.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The transactions may provide shareholders with insights into management's views on the company's stock value.

Key Dates